| Literature DB >> 23983781 |
You Ning1, Jian-Hua Huang, Shi-Jin Xia, Qin Bian, Yang Chen, Xin-Min Zhang, Jing-Cheng Dong, Zi-Yin Shen.
Abstract
Adult neural stem cells (NSCs) persist throughout life to replace mature cells that are lost during turnover, disease, or injury. The investigation of NSC creates novel treatments for central nervous system (CNS) injuries and neurodegenerative disorders. The plasticity and reparative potential of NSC are regulated by different factors, which are critical for neurological regenerative medicine research. We investigated the effects of Psoralen, which is the mature fruit of Psoralea corylifolia L., on NSC behaviors and the underlying mechanisms. The self-renewal and proliferation of NSC were examined. We detected neuron- and/or astrocyte-specific markers using immunofluorescence and Western blotting, which could evaluate NSC differentiation. Psoralen treatment significantly inhibited neurosphere formation in a dose-dependent manner. Psoralen treatment increased the expression of the astrocyte-specific marker but decreased neuron-specific marker expression. These results suggested that Psoralen was a differentiation inducer in astrocyte. Differential gene expression following Psoralen treatment was screened using DNA microarray and confirmed by quantitative real-time PCR. Our microarray study demonstrated that Psoralen could effectively regulate the specific gene expression profile of NSC. The genes involved in the classification of cellular differentiation, proliferation, and metabolism, the transcription factors belonging to Ets family, and the hedgehog pathway may be closely related to the regulation.Entities:
Year: 2013 PMID: 23983781 PMCID: PMC3745865 DOI: 10.1155/2013/452948
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Effects of Psoralen on neurosphere formation of neural stem cells in vitro. Single NSCs at a density of 500 cells/well were cultured in normal growth medium (NGM) containing DMEM/F12 supplemented with hrFGF for 7 days to form various size of neurospheres (a). The neurospheres expressed NSC marker nestin (b). Single NSCs were exposed to NGM, DMSO (0.1%), and 10, 50, 100 nM Psoralen dissolved in DMSO (0.1%), respectively. Psoralen caused a significant decrease in frequency of neurosphere formation (c). Scale bars: 100 μm. Results were expressed as mean ± S.D. of six independent experiments. *P < 0.05 versus NGM.
Figure 2Effects of Psoralen on the proliferation of NSC. Single NSCs were plated at a density of 5000 cells per well in PDL-coated 96-well plate for 12 h. Then, cells were subjected to 10 nM EdU for 2 h, followed by addition of 100 nM OA (b) or not (a). Then Edu immunofluorescence analysis was performed. The cell nuclei were counterstained with DAPI. The percentage of EdU-positive cells in total of 1000 cells was calculated. As a result, Psoralen significantly inhibited the DNA incorporation (c). Scale bars: 100 μm. Results were expressed as mean ± S.D. from four independent experiments. *P < 0.05 versus control.
Figure 3Effects of Psoralen on the differentiation of NSC. Single NSCs were seeded at a density of 50 cells/μL in PDL-coated 96-well plate in differentiation medium for 48 h without Psoralen (a, b) or with 100 nM Psoralen (c, d). Cells were subjected to primary antibodies of GFAP, TuJ1 and corresponding secondary antibodies and visualized with Alexa-conjugated 594 F(ab)′2 goat anti-rabit antibody and 488 Alexa-conjugated goat anti mouse IgG (H + L). The ratio of GFAP, TuJ1-positive cells against DAPI-stained cells was calculated. Psoralen significantly increased the GFAP-positive cells and decreased the TuJ1-positive cells (e). The same cells were performed using Western blotting. Psoralen significantly increased the GFAP, decreased the TuJ1 protein expression (f). Scale bars: 100 μm. Results were expressed as mean ± S.D. from three independent experiments. *P < 0.05 versus control.
Figure 4The expression profiles of these representative genes including CREM, Kit1, Shh, TBX1, and Bcl2l11 were confirmed by quantitative real-time PCR, which validates our data. Our data sets could be used for further bioinformatic analyses.
The list of the differentially expressed tags of DAVID gene functional classification.
| Functional annotation clustering | Gene number | Gene bank accession | Description |
|---|---|---|---|
| Apoptosis | 12 | BC058175 | BCL2-like 11 (apoptosis facilitator) |
| AK144648 | CASP2 and RIPK1 domain containing adaptor with death domain | ||
| AK186862 | Cytokine-induced apoptosis inhibitor 1 | ||
| AK049134 | Ectodysplasin A2 isoform receptor | ||
| AK010878 | Hypothetical protein LOC100233175 | ||
| AK041961 | Kit ligand | ||
| XM_001476612 | Predicted gene 15753, Sp110 nuclear body protein | ||
| BC016606 | Proteasome (prosome, macropain) assembly chaperone 2, similar to Clast3 protein | ||
| BC063087 | Sonic hedgehog | ||
| AK082974 | Sphingomyelin synthase 1 | ||
| BC027335 | Tectonic family member 3 | ||
| AK183781 | Zinc finger, DHHC domain containing 16 | ||
|
| |||
| Regulation of apoptosis | 11 | BC058175 | BCL2-like 11 (apoptosis facilitator) |
| AK144648 | CASP2 and RIPK1 domain containing adaptor with death domain | ||
| AK186862 | Cytokine-induced apoptosis inhibitor 1 | ||
| BC080315 | Glutamate receptor, metabotropic 7 | ||
| BC152841 | Heat shock protein 1B, heat shock protein 1A, heat shock protein 1-like | ||
| AK010878 | Hypothetical protein LOC100233175 | ||
| AK041961 | Kit ligand | ||
| AK160757 | Microphthalmia-associated transcription factor | ||
| XM_001476612 | Sp110 nuclear body protein | ||
| BC016606 | Proteasome (prosome, macropain) assembly chaperone 2; similar to Clast3 protein | ||
| AK082974 | Sphingomyelin synthase 1 | ||
|
| |||
| Multicellular organism reproduction | 10 | BC058175 | BCL2-like 11 (apoptosis facilitator) |
| AK086849 |
| ||
| AY738720 | cAMP responsive element modulator | ||
| BC152841 | Heat shock protein 1B, heat shock protein 1A, heat shock protein 1-like | ||
| AK160943 | Heterogeneous nuclear ribonucleoprotein L-like, glutathione peroxidase 4 | ||
| AK041961 | Kit ligand | ||
| AK078529 | Neuralized homolog 1A (Drosophila); similar to neuralized 1 | ||
| XM_001474694 | Rik protein | ||
| BC115962 | Germ cell-less homolog 1 | ||
| BC061175 | Testis-specific serine kinase 2 | ||
|
| |||
| Cellular protein catabolic process | 9 | BC058593 | SUMO1/sentrin specific peptidase 7 |
| AK053749 | WW domain containing E3 ubiquitin protein ligase 2 | ||
| BC040367 | Ligand of numb-protein X 1 | ||
| BC128498 | Myosin, heavy polypeptide 9, nonmuscle | ||
| BC115962 | Germ cell-less homolog 1 | ||
| XM_001474694 | Rik protein | ||
| XM_354829 | Seven in absentia homolog 3 (Drosophila) | ||
| BC059027 | Similar to midline 1, midline 1 | ||
| BC026983 | Ubiquitin specific peptidase 39 | ||
|
| |||
| Epidermis development | 4 | BC152326 | Involucrin, RIKEN cDNA 1110019C06 gene |
| BC148438 | Small proline-rich protein 2E, small proline-rich protein 2F, Small proline-rich protein 2I | ||
| BC156163 | Small proline-rich protein 2H | ||
| BC063087 | Sonic hedgehog | ||
|
| |||
| Cell differentiation | 3 | AK041961 | Kit ligand |
| AF349658 | Similar to T-box 1; T-box 1 | ||
| BC063087 | Sonic hedgehog | ||
|
| |||
| Regulation of cell cycle process | 3 | AK018243 | ZW10 homolog (Drosophila), centromere/kinetochore protein |
| BC016606 | Proteasome (prosome, macropain) assembly chaperone 2, similar to Clast3 protein | ||
| AK003451 | Timeless interacting protein | ||
The list of the differentially expressed tags of DAG analysis of gene categories.
| Categories | Gene bank accession | Description |
|---|---|---|
| Establishment of cell polarity | 17886 | Myosin, heavy polypeptide 9, nonmuscle |
| 20423 | Sonic hedgehog | |
| Myotube differentiation | 17886 | Myosin, heavy polypeptide 9, nonmuscle |
| 20423 | Sonic hedgehog | |
| Positive regulation of angiogenesis | 14461 | GATA binding protein 2 |
| 12394 | Runt-related transcription factor 1 | |
| Glycolipid metabolic process | 14421 |
|
| 12916 | cAMP responsive element modulator | |
| Regulation of pigmentation during development | 12125 | BCL2-like 11 (apoptosis facilitator) |
| 17311 | Kit ligand | |
| Negative regulation of DNA metabolic process | 66131 | Timeless interacting protein |
| 72836 | Protection of telomeres 1B | |
| Microtubule polymerization or depolymerization | 17318 | Midline 1 |
| 17997 | Neural precursor cell expressed, developmentally downregulated gene 1 | |
| Telomere organization | 15511 | Heat shock protein 1B |
| 72836 | Protection of telomeres 1B | |
| Mesenchymal cell development | 21380 | T-box 1 |
| 20423 | Sonic hedgehog | |
| 17311 | Kit ligand | |
| Neural crest cell differentiation | 21380 | T-box 1 |
| 20423 | Sonic hedgehog | |
| 17311 | Kit ligand |
The list of the differentially expressed tags of matched KEGG pathway analysis.
| KEGG pathways | Gene number matched | Gene bank accession | Description |
|---|---|---|---|
| MAPK signaling pathway | 5 | BC119041 | RAS-related C3 botulinum substrate 3 |
| BC052705 | Dual specificity phosphatase 8 | ||
| BC152841 | Heat shock protein 1B | ||
| BC006037 | Mitogen-activated protein kinase kinase kinase kinase 3 | ||
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| Pathways in cancer | 5 | BC119041 | RAS-related C3 botulinum substrate 3 |
| AK041961 | Kit ligand | ||
| AK160757 | Microphthalmia-associated transcription factor | ||
| AK155262 | Runt-related transcription factor 1 | ||
| BC063087 | Sonic hedgehog | ||
| Spliceosome | 4 | AK040680 | Cell division cycle 40 homolog (yeast) |
| BC152841 | Heat shock protein 1B | ||
| BC004793 | Poly(rC) binding protein 1 | ||
| BC026983 | Ubiquitin specific peptidase 39 | ||
| Axon guidance | 4 | AK089130 | Eph receptor A5 |
| BC119041 | RAS-related C3 botulinum substrate 3 | ||
| AK171860 | Actin-binding LIM protein 1 | ||
| AK053689 | Netrin G1 | ||
| Hedgehog signaling pathway | 3 | AK149310 | Casein kinase 1, gamma 1 |
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| BC063087 | Sonic hedgehog | ||
| Viral myocarditis | 3 | BC119041 | RAS-related C3 botulinum substrate 3 |
| BC128498 | Myosin, heavy polypeptide 9, nonmuscle | ||
| BC156199 | v-abl Abelson murine leukemia viral oncogene homolog 2 | ||
| Melanogenesis | 3 | AK041961 | Kit ligand |
| AK160757 | Microphthalmia-associated transcription factor | ||
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| Oxidative phosphorylation | 3 | AK078484 | ATP synthase |
| XM_895878 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 | ||
| AK149674 | NADH dehydrogenase (ubiquinone) Fe-S protein 8 | ||
| Cytokine-cytokine receptor interaction | 3 | AK049134 | Ectodysplasin A2 isoform receptor |
| AY221616 | Interleukin 15 receptor, alpha chain | ||
| AK041961 | Kit ligand | ||
| Cysteine and methionine metabolism | 2 | AK085987 | 5-Methyltetrahydrofolate-homocysteine methyltransferase |
| BC094469 | Mercaptopyruvate sulfurtransferase | ||
| Prion diseases | 2 | BC152841 | Heat shock protein 1B |
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| SNARE interactions in vesicular transport | 2 | AK030538 | Vesicle transport through interaction with t-SNAREs homolog 1A |
| BC086925 | Vesicle-associated membrane protein 5 | ||
| Adherens junction | 2 | AK137694 | LIM domain only 7 |
| BC119041 | RAS-related C3 botulinum substrate 3 | ||
| Gap junction | 2 | AK031305 | Guanylate cyclase 1, soluble, alpha 3 |
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| Systemic lupus erythematosus | 2 | BC152885 | Histone H4 |
| K02799 | Complement C4 precursor | ||
| Vascular smooth muscle contraction | 2 | AK031305 | Guanylate cyclase 1, soluble, alpha 3 |
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| Natural killer cell mediated cytotoxicity | 2 | BC119041 | RAS-related C3 botulinum substrate 3 |
| AY860969 | Natural killer cell receptor Ly49C | ||
| Parkinson's disease | 2 | AK078484 | ATP synthase |
| AK149674 | NADH dehydrogenase (ubiquinone) Fe-S protein 8 | ||
| Tight junction | 2 | BC002003 | Claudin 1 |
| BC128498 | Myosin, heavy polypeptide 9, non-muscle | ||
| Ubiquitin mediated proteolysis | 2 | AK053749 | WW domain containing E3 ubiquitin protein ligase 2 |
| BC059027 | Midline 1 | ||
| Insulin signaling pathway | 2 | BC054533 | Protein kinase, cAMP dependent, catalytic, beta |
| AK172276 | Regulatory associated protein of MTOR, complex 1 | ||
| Wnt signaling pathway | 2 | BC119041 | RAS-related C3 botulinum substrate 3 |
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| Purine metabolism | 2 | AK031305 | Guanylate cyclase 1, soluble, alpha 3 |
| AK036090 | Phosphodiesterase 8B | ||
| Alzheimer's disease | 2 | AK078484 | ATP synthase |
| AK149674 | NADH dehydrogenase (ubiquinone) Fe-S protein 8 | ||
| Chemokine signaling pathway | 2 | BC010478 | Hemopoietic cell kinase |
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta | ||
| Huntington's disease | 2 | AK078484 | ATP synthase |
| AK149674 | NADH dehydrogenase (ubiquinone) Fe-S protein 8 | ||
| Regulation of actin cytoskeleton | 2 | BC119041 | RAS-related C3 botulinum substrate 3 |
| BC128498 | Myosin, heavy polypeptide 9, non-muscle | ||
| Neuroactive ligand-receptor interaction | 2 | AK050472 | Gastric inhibitory polypeptide receptor |
| BC080315 | Glutamate receptor, metabotropic 7 | ||
| Olfactory transduction | 2 | BC104278 | Olfactory receptor 1173 |
| BC054533 | Protein kinase, cAMP dependent, catalytic, beta |
The list of the differentially expressed tags of matched transcription factor binding sites.
| Transcription factor | Gene family | Target gene (>70 hits) |
|---|---|---|
| Sfpi1_1 | Ets | 139 |
| Elf3_1 | Ets | 131 |
| Zfp105_1 | Beta-Beta-Alpha-zinc finger | 114 |
| Tbp_1 | TATA binding | 110 |
| Foxj1_1 | Forkhead | 100 |
| Sox12_1 | High-mobility group | 95 |
| Tcfap2a_1 | Helix-Loop-Helix | 94 |
| Zic2_2 | Beta-Beta-Alpha-zinc finger | 93 |
| Irf3_1 | IRF | 92 |
| Foxj3_2 | Forkhead | 91 |
| Zic3_2 | Beta-Beta-Alpha-zinc finger | 89 |
| Sox11_1 | High-mobility group | 89 |
| Sox4_1 | High-mobility group | 86 |
| Klf7_1 | Beta-Beta-Alpha-zinc finger | 85 |
| Arid5a_1 | Arid | 83 |
| Ehf_1 | Ets | 83 |
| Sox11_2 | High-mobility group | 80 |
| Sox18_1 | High-mobility group | 80 |
| Osr1_2 | Beta-Beta-Alpha-zinc finger | 79 |
| Sox5_1 | High-mobility group | 79 |
| Sp4_1 | Beta-Beta-Alpha-zinc finger | 77 |
| Zscan4_2 | Beta-Beta-Alpha-zinc finger | 76 |
| Tcfap2e_1 | Helix-Loop-Helix | 76 |
| Egr1_2 | Beta-Beta-Alpha-zinc finger | 75 |
| Foxl1_2 | Forkhead | 75 |
| Foxa2_1 | Forkhead | 75 |
| Tcfap2c_1 | Helix-Loop-Helix | 75 |
| Sox14_2 | High-mobility group | 75 |
| Smad3_1 | MH1 | 75 |
| Sox17_1 | High-mobility group | 74 |
| Hic1_2 | Beta-Beta-Alpha-zinc finger | 73 |
| Sox21_2 | High-mobility group | 72 |
| Zic1_2 | Beta-Beta-Alpha-zinc finger | 71 |
| Tcf1_2 | Homeo | 71 |
| Zfp740_1 | Beta-Beta-Alpha-zinc finger | 70 |